• Amorolfine Hydrochloride: Research Guide

  2026-08-25

  Amorolfine Hydrochloride is a morpholine-derived antifungal reagent for controlled studies of fungal membrane biology. Its research value is strongest when membrane perturbation is interpreted alongside cell-surface stress, ploidy, solvent, and viability controls.

• Crizotinib Hydrochloride in Assay Design

  2026-08-25

  Crizotinib hydrochloride can serve as a mechanistic perturbation tool for separating kinase dependence from stromal protection in patient-derived gastric cancer models. This article presents an assay-design framework grounded in matched organoid–assembloid comparisons, target engagement, and response interpretation.

• Levofloxacin Workflows for Antibacterial and Bone Research

  2026-08-24

  Levofloxacin supports complementary antibacterial, osteoblast, and chondrocyte workflows by linking bacterial DNA replication inhibition with measurable effects on bone and cartilage biology. This practical guide covers assay setup, exposure design, calcium deposition analysis, resistance-aware interpretation, and troubleshooting for SKU B1959.

• KU-60019: ATM Kinase Inhibitor Workflow Guide

  2026-08-24

  Build reproducible KU-60019 experiments for glioma radiosensitization, DNA damage response inhibition, and migration assays. A practical workflow also shows how to test ATM–metabolism combinations inspired by high-grade serous ovarian cancer research without overstating cross-model evidence.

• Gramine–CUL3–MTDH Axis in TNBC Ferroptosis

  2026-08-23

  The reference study identifies Gramine as a natural indole alkaloid that suppresses triple-negative breast cancer by engaging a CUL3–MTDH regulatory pathway linked to ferroptosis. Its integrated chemical, biochemical, cellular, and xenograft experiments provide a mechanistic framework for studying ferroptosis and MTDH ubiquitination in cancer biology research.

• Recombinant Annexin V Maps Cardiomyocyte Death

  2026-08-22

  The reference study introduced labeled human recombinant Annexin V as an in vivo probe for early phosphatidylserine externalization after myocardial ischemia and reperfusion. By resolving cell-death timing before conventional DNA-fragmentation methods and responding to a cell-death–blocking intervention, the work established a practical framework for testing cardioprotective strategies.

• Candida krusei Phase-Specific Apoptosis in BMECs

  2026-08-22

  The reference study shows that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial-cell apoptosis through different signaling programs. Its phase-resolved co-culture design links yeast-associated injury mainly to mitochondrial signaling and hypha-associated injury to death ligand/receptor signaling, with TLR- and MAPK-related pathways contributing to both responses.

• Mitochondrial Calcium Signaling Represses Ferroptosis

  2026-08-21

  The reference study identifies a direct mechanistic link between mitochondrial calcium uptake, GPX4 acetylation, and repression of ferroptotic cell death. By combining mouse genetics, cancer-cell models, mutational analysis, and structural interpretation, it shows how MCU-dependent mitochondrial metabolism sustains GPX4 activity and tumor growth.

• GW 4869: Exosome Workflow for Osteogenesis

  2026-08-20

  Use GW 4869 to separate extracellular-vesicle release effects from direct sphingolipid signaling in BMSC and osteogenesis assays. This practical workflow covers donor-cell treatment, Li-Exo comparisons, controls, dosing, and troubleshooting for more defensible exosome biology.

• Lysosomal Exocytosis in MPS IVA Cartilage

  2026-08-20

  A 2026 Disease Models & Mechanisms study identifies enhanced lysosomal exocytosis as a disease-associated feature in galns-mutant zebrafish cartilage. Its central contribution is to connect altered lysosome trafficking with reduced cathepsin activity, disrupted TGFβ/BMP signaling, and abnormal glycosaminoglycan distribution rather than attributing skeletal pathology to storage burden alone.

• Ang II–HIF-1α-HILPDA Axis in NPC Radioresistance

  2026-08-19

  The reference study identifies a local angiotensin II–AGT–HIF-1α–HILPDA circuit that suppresses ferroptosis and promotes radioresistance in nasopharyngeal carcinoma. Its experiments connect lipid-droplet regulation with radiation response and suggest that combining angiotensin II receptor blockade with ferroptosis induction merits further preclinical investigation.

• A-1210477: Mapping MCL-1 Apoptotic Dependency

  2026-08-19

  A-1210477 is an MCL-1 inhibitor for resolving how cancer cells depend on mitochondrial apoptosis. This guide connects binding, BAX/BAK competence, orthogonal assay design, and translational interpretation without overstating in vivo potential.

• Batimastat (BB-94): From MMPs to Synapses

  2026-08-18

  A translational framework for using Batimastat (BB-94) to connect matrix metalloproteinase activity with tumor invasion, angiogenesis, and spatially controlled BDNF processing at developing neuromuscular synapses.

• GLP-1 (9-36) amide for Receptor Studies

  2026-08-18

  GLP-1 (9-36) amide supports controlled blockade experiments that separate GLP-1 receptor activity from ligand cross-reactivity. This guide translates cAMP assay findings into practical workflows for GPCR signaling, metabolic regulation, and type 2 diabetes research.

• LC–MS/MS Maps GS-441524 Prodrug Conversion

  2026-08-17

  A January 2026 Microchemical Journal study established an LC–MS/MS workflow for tracking conversion of the novel GS-441524 prodrug NGP-1 to GS-441524 across gastric fluid, blood, liver microsomes, and a rat liver-injury model. Its findings support a sequential absorption and biotransformation model that can inform oral prodrug design and GS-441524 pharmacokinetics studies.

8082 records 1/539 page Next 12345 下5页 Last page